J 119 THR 18 -9.430 -10.416
J 120 THR 4 -11.581 -10.709
J 121 PHE 25 -13.269 -14.618
J 122 LYS 11 -14.756 -14.324
J 123 LEU 29 -18.075 -19.331
J 124 ALA 16 -21.703 -21.047
J 125 ALA 20 -21.532 -21.356
J 126 CYS 25 -22.399 -22.698
J 127 VAL 21 -20.689 -20.725
J 128 THR 17 -19.884 -19.553
J 129 LEU 19 -20.674 -20.481
J 130 ARG 11 -18.100 -17.283
J 131 CYS 18 -17.879 -17.893
J 132 THR 8 -14.265 -13.545
J 133 ASN 10 -10.594 -10.525
J 134 ALA 15 -10.068 -10.635
J 135 THR 3 -7.527 -7.006
J 136 ILE 13 -6.649 -7.379
J 137 ASN 5 -4.044 -4.154
J 148 GLY 0 -3.983 -3.525 <=B
J 149 SER 3 -4.461 -4.293
J 150 LEU 3 -6.921 -6.470
J 151 THR 17 -7.265 -8.385
J 152 GLU 3 -7.847 -7.290
J 153 GLU 8 -7.173 -7.268
J 154 VAL 12 -11.259 -11.344
J 155 LYS 17 -13.940 -14.292
J 156 ASN 12 -15.070 -14.717
J 157 CYS 22 -17.894 -18.366
J 158 SER 8 -17.125 -16.075
J 159 PHE 29 -18.107 -19.360
J 160 ASN 16 -14.384 -14.570
J 161 ILE 11 -13.677 -13.369
J 162 THR 20 -10.785 -11.845
J 163 THR 7 -6.020 -6.133
J 164 GLU 2 -3.078 -2.954 <=B
J 165 LEU 11 -4.359 -5.122
J 166 ARG 5 -3.097 -3.316 <=B
J 167 ASP 6 0.913 0.118 <=B
J 168 LYS 5 -2.621 -2.894 <=B
J 169 LYS 18 -7.724 -8.905
J 170 GLN 2 -8.353 -7.623
J 171 LYS 5 -12.012 -11.206
J 172 ALA 16 -13.831 -14.080
J 173 TYR 13 -15.735 -15.421
J 174 ALA 17 -17.033 -17.030
J 175 LEU 10 -15.426 -14.802
J 176 PHE 19 -15.307 -15.732
J 177 TYR 6 -11.397 -10.776
J 178 ARG 11 -9.274 -9.473
J 179 PRO 0 -4.513 -3.994
J 180 ASP 0 -3.223 -2.852 <=B
J 189 SER 2 -9.260 -8.425
J 190 GLU 14 -13.715 -13.748
J 191 TYR 16 -16.400 -16.354
J 192 ILE 16 -19.703 -19.277
J 193 LEU 22 -20.729 -20.875
J 194 ILE 18 -20.519 -20.230
J 195 ASN 17 -20.153 -19.791
J 196 CYS 19 -21.290 -21.027
J 197 GLN 7 -19.201 -17.798
J 198 THR 10 -19.019 -17.982
J 199 THR 15 -15.156 -15.138
J 200 THR 6 -12.805 -12.022
J 201 THR 21 -12.005 -13.039
J 202 GLU 0 -11.077 -9.803
J 203 ALA 20 -11.260 -12.265
J 204 VAL 1 -9.527 -8.546
J 205 ASP 1 -9.991 -8.957
J 206 ALA 11 -12.043 -11.923
J 207 ALA 0 -10.374 -9.181
J 208 THR 8 -10.285 -10.022
J 209 ALA 25 -13.582 -14.895
J 210 ALA 9 -13.394 -12.889
J 211 LYS 6 -11.024 -10.446
J 212 VAL 16 -11.877 -12.351
J 213 PHE 33 -13.248 -15.519
J 214 LYS 10 -11.179 -11.043
J 215 GLN 6 -8.781 -8.462
J 216 TYR 23 -10.228 -11.697
J 217 ALA 26 -13.068 -14.556
J 218 ASN 5 -8.120 -7.761
J 219 ASP 6 -7.280 -7.133
J 220 ASN 20 -9.873 -11.037
J 221 GLY 10 -10.468 -10.414
J 222 ILE 28 -15.304 -16.764
J 223 ASP 14 -13.803 -13.825
J 224 GLY 30 -15.661 -17.310
J 225 GLU 13 -15.730 -15.416
J 226 TRP 20 -15.412 -15.939
J 227 THR 15 -16.518 -16.344
J 228 TYR 14 -14.887 -14.785
J 229 ASP 8 -13.587 -12.945
J 230 ASP 2 -11.328 -10.255
J 231 ALA 1 -10.120 -9.071
J 232 THR 12 -12.053 -12.047
J 233 LYS 15 -12.800 -13.053
J 234 THR 12 -15.091 -14.735
J 235 PHE 31 -17.974 -19.472
J 236 THR 17 -19.644 -19.340
J 237 VAL 25 -19.697 -20.307
J 238 THR 18 -20.390 -20.115
J 239 GLU 29 -18.175 -19.420
J 240 GLY 26 -17.018 -18.051
J 241 LEU 14 -17.324 -16.941
J 242 GLU 5 -14.972 -13.826
J 243 VAL 22 -17.111 -17.674
J 244 LEU 14 -17.412 -17.020
J 245 PHE 6 -13.579 -12.708

Identified 6 B-Cell epitope residues out of 109 total residues